Figure 3. Overall survival.

1 Hazard ratios are reported for rates on Paclitaxel+Reovirus to Paclitaxel Alone. This analysis occurred after the primary analysis was conducted.
2 Analysis stratified by measurable disease (Yes/No) and platinum-free interval (≤ 182 days versus > 182 days).